Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries ...

CVS Health’s first quarter results reflected steady execution across its core businesses, with management highlighting ...

The FDA is investigating two deaths in non-ambulatory Duchenne muscular dystrophy patients who received a Sarepta gene ...

More than 50 insurers have pledged to streamline and simplify the prior authorization process through six new commitments.

Louisiana filed several lawsuits accusing pharmaceutical giant CVS of abusing customer information and using its dominant ...

The health sector makes headlines with global reactions to bird flu impacting chicken exports and the ongoing narrative of ...

CVS adds Wegovy to its top formularies and bolsters its Weight Management program, aiming to expand access while cutting costs.

Beyond current successes, Eli Lilly is innovating with a potential game-changing oral GLP-1, orforglipron. Read why I ...

The nation’s major health insurers are promising to scale back and improve a widely despised practice that leads to care ...

The U.S. joined Israel's war against Iran, striking three nuclear sites. Stock futures were little changed and oil was barely higher, as traders watched Iran's reaction. U.S. health insurers are ...

Approximately 15 million Americans are on a GPL-1 or better known as Ozempic, Wegovy and Zepbound but there will be upcoming ...